Nguyen Diem 4

What Happened

• Nguyen Diem, a director of Candel Therapeutics, received a grant of 32,000 stock options (reported as a derivative award) on June 23, 2026. The options were reported at $0.00 per share (no cash paid at grant). This is a compensatory award rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-23; reported on Form 4 filed 2026-06-24 (timely filing).
• Transaction type/code: Award/Grant (A); derivative security (option).
• Amount: 32,000 options; reported price $0.00 (grant value not reported as cash).
• Shares owned after transaction: Not specified in the filing.
• Notable footnote: Options vest based on time — they vest and become exercisable on the earlier of (i) June 23, 2027 or (ii) the next Annual Meeting of Stockholders; vesting stops if the director resigns or leaves the board unless the board decides otherwise.

Context

• This is a standard director compensation grant (an option award) and does not represent an open‑market purchase or sale. The options are subject to future vesting and therefore are not immediately exercisable or liquid. Such awards are routine for board service and should be interpreted as compensation, not a direct bullish or bearish trade by the insider.